Destiny Pharma plc
DEST.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 438.2% | 14.4% | 984.6% | – |
| Gross Profit | £0 | £0 | £0 | -£0 |
| % Margin | 99.3% | 92% | 90.7% | -35.6% |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -789.3% | -5,025.3% | -4,646.8% | -52,495% |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -680.3% | -4,209.5% | -3,954.4% | -43,462.5% |
| EPS Diluted | -0.062 | -0.093 | -0.089 | -0.12 |
| % Growth | 32.6% | -3.8% | 25.7% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |